| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |